Shorter trial authorisation timelines for ATMP trials in the US are an advantage for biotechs, say experts. Although the ...

Amvuttra is now approved in the US to treat both cardiomyopathy and polyneuropathy manifestations of ATTR amyloidosis.

The Menarini Group, along with its subsidiary Stemline Therapeutics, has announced a partnership with VisualDx to enhance the ...

NMPA has granted conditional approval for Hutchmed’s Tazverik to treat adults with relapsed or refractory (R/R) follicular ...

J&J is the latest pharma company to announce a major US investment, committing to a $55bn influx in the next four years.

Ahead of World Tuberculosis Day on 24 March, the WHO has said that global funding cuts are curtailing efforts to fight the ...

Sanofi’s move for Dren Bio’s clinical asset boosts its immunology-focused strategy of becoming a leader in the field.

Servier and Black Diamond Therapeutics have signed a licencing agreement for targeted therapy, BDTX-4933, aimed at addressing ...

OBT has entered a multi-year partnership with Roche to discover antibody-based therapeutics for cancer treatment.

Biotech and biopharma companies have battled with a drought of private investment in recent years but could now face ...

Investigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing Alzheimer's symptoms by 50%.

Purdue is expected to raise and contribute $900m while dissolving and transforming into a new public benefit company. The non ...